What is the current market size?

The Genetically Modified Rat market size was valued at USD 1.2 billion in 2023, driven by demand in biomedical research and drug development.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.5% from 2024 to 2030, with increasing applications in personalized medicine.

What are the key drivers of market growth?

Key drivers include advancements in gene-editing technologies, rising R&D investments, and growing demand for disease modeling.

What challenges does the market face?

High development costs, regulatory complexities, and ethical concerns regarding animal testing hinder market expansion.

Which regions are leading the market?

North America dominates the market, followed by Europe, due to advanced research infrastructure and strong biotech industries.

Who are the top companies in the space?

Leading players include Charles River Laboratories, Taconic Biosciences, and Envigo, focusing on innovative genetic model solutions.

What future opportunities exist?

Emerging opportunities lie in Asia-Pacific's growing biotech sector, CRISPR applications, and expanding oncology research.

How is technology impacting the market?

CRISPR-Cas9 and AI-driven modeling are revolutionizing precision and efficiency in creating genetically modified rat models.

What is the regulatory landscape?

Regulations by the FDA and EMA ensure safety and ethics, while varying regional guidelines pose compliance challenges for global players.

Genetically Modified Rat Growth Analysis & Future Outlook 2033

Genetically Modified Rat by Application (Drug Discovery, Basic Research, Toxicity Test, Parasitological Study, Hereditary Disease Study, Others), by Types (Disease Model, Oncology Research Model, Immunological Research Model, Conventional Gene Modification Model, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1.73 billion

CAGR: 10.04%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 139

Forecast Period: 2026 - 2033

Market Size: $1.73 billion

CAGR: 10.04%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Genetically Modified Rat Market Overview

The Genetically Modified Rat market encompasses specialized laboratory rats engineered to model human diseases, accelerate drug discovery, and validate therapeutic targets. With increasing demand for precision medicine and biopharma R&D, this market is a cornerstone of translational research. The Genetically Modified Rat market size is estimated at $1.2 billion in 2025, reflecting robust growth outlook amid advancements in gene-editing technologies. The market is projected to grow at a CAGR of 8.3% from 2026 to 2033, driven by rising investments in oncology and neurology research, regulatory support for preclinical models, and the cost-efficiency of rat-based studies compared to mice.

Loading chart…

Key industry expansion forces include CRISPR-Cas9 adoption for precise genetic modifications, rising demand for disease-specific models (e.g., Alzheimer’s and diabetes), and strategic collaborations between model organism providers and pharmaceutical firms. North America remains the largest region due to its dominance in biotech innovation, while Asia-Pacific will experience the fastest growth, fueled by cost-competitive contract research services in India and China. Regulatory harmonization under the FDA and EMA further supports market scalability, ensuring genetically modified rats remain indispensable for drug safety testing and biomarker discovery in the 2033 forecast horizon.

Report Overview

Report Attribute	Details
Market size value in 2025	1.73 billion
Revenue forecast in 2033	3.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Shanghai Model Organisms Center,Inc.; Gem Pharmatech Co.,Ltd.; Shanghai SLAC; Joinn Laboratories; Crown Biosciences; Pharmalegacy; Syngene International; Janvier Labs; GenOway; Psychogenics; Horizon Discovery Group; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Genetically Modified Rat market is propelled by rising demand in biomedical research for modeling complex diseases such as cancer and neurodegenerative disorders, enabling accelerated drug discovery and precision medicine development.

Advancements in gene-editing technologies like CRISPR-Cas9 have significantly reduced production costs and improved genetic precision, expanding accessibility for academic and commercial stakeholders and driving growth forecast optimism.

Restraints2 items

Stringent regulatory frameworks across regions, including prolonged approval timelines for genetically modified organisms (GMOs), create operational delays and increase compliance burdens for market players.

Ethical concerns and public resistance toward animal testing, amplified by animal rights advocacy groups, may deter investment and adoption in the Genetically Modified Rat market, particularly in developed markets.

Opportunities2 items

Growing adoption of genetically modified rats in preclinical trials for personalized medicine applications presents a high-growth niche, driven by the need for patient-specific disease models and therapeutic validation.

Emerging markets in Asia-Pacific and Latin America offer untapped potential as biopharmaceutical investments surge, with local partnerships enabling cost-effective production and regional market penetration.

Challenges2 items

High R&D expenditures for strain development and customization, coupled with the risk of low commercial viability for niche genetic models, strain profitability in the Genetically Modified Rat market size.

Supply chain fragility due to specialized breeding requirements and biosecurity protocols disrupts consistent supply, particularly amid global logistics bottlenecks and geopolitical trade tensions.

Market Segmentation

Loading chart…

The Genetically Modified Rat segmentation by application reveals distinct contributions to market dynamics. Biomedical research constitutes the largest segment, driven by the use of GM rats in modeling human diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. These models enable preclinical testing of therapeutic interventions, accelerating drug development pipelines. Pharmaceutical development follows, where GM rats are engineered to test drug efficacy and toxicity, ensuring regulatory compliance. Together, these two applications account for over 80% of the market value. Toxicology screening and agricultural research represent niche but growing segments, addressing chemical safety assessments and crop-pest interaction studies, respectively. The application diversity underscores the versatility of Genetically Modified Rat segmentation in supporting cross-disciplinary scientific advancements.

By types, the Genetically Modified Rat market is categorized into knockout rats and transgenic rats, each contributing uniquely to research objectives. Knockout rats, engineered to have specific genes inactivated, are critical for studying gene function and disease mechanisms, accounting for ~40% of the market. Transgenic rats, which incorporate exogenous genetic material, dominate the remaining 60%, facilitating the study of gene overexpression, protein production, and human disease modeling. Subtypes such as conditional knockout rats and CRISPR-edited rats further diversify the market, offering precision in genetic manipulation. The demand for transgenic rats is particularly high in oncology and immunology research, while knockout rats remain essential in basic biological research. This typological segmentation reflects the technical advancements and application-specific demand shaping the overall market size.

Genetically Modified Rat Segmentation Breakdown13 items

Application

Drug Discovery

Basic Research

Toxicity Test

Parasitological Study

Hereditary Disease Study

Others

Types

Disease Model

Oncology Research Model

Immunological Research Model

Conventional Gene Modification Model

Others

Regional Insights

Loading chart…

The Genetically Modified Rat market growth is led by North America, accounting for ~45% of global demand, driven by advanced biotechnology ecosystems, high R&D investments, and robust adoption in pharmaceutical and biomedical research. Asia Pacific is the fastest-growing region, expanding at a CAGR of 12%, fueled by rising healthcare investments, supportive government policies, and a surge in contract research organizations (CROs). Europe holds ~30% of the market, with stringent regulatory frameworks and a mature research infrastructure sustaining steady adoption. Latin America and Middle East & Africa represent ~7% and ~3% respectively, with growth supported by emerging partnerships, infrastructure modernization, and increasing awareness of genetically modified models in disease modeling.

Key Regional Drivers5 items

North America: High adoption due to cutting-edge infrastructure, strong private-sector funding, and a focus on precision medicine.

Europe: Regulatory alignment under the EU’s GMO Directive, coupled with cross-border collaborations in academic research.

Asia Pacific: Government grants (e.g., India’s Biotechnology Regulatory Authority) and rising demand for preclinical studies in oncology.

Latin America: Public-private partnerships enhancing lab capabilities and regional policy reforms to attract biotech investments.

Middle East & Africa: Growing healthcare modernization efforts and training programs to standardize genetic research protocols.

Competitive Landscape

The Genetically Modified Rat competitive landscape is moderately consolidated, with a mix of global players and regional specialists. Key players leverage product innovation, regulatory approvals, and specialized certifications to differentiate offerings. Pricing strategies vary by application segment, with premium models commanding higher margins in research-intensive fields. Distribution channels remain fragmented, though partnerships with academic institutions and biopharma firms strengthen market access. Strategic differentiation centers on genomic editing precision, animal welfare standards, and tailored model development capabilities.

Competitors prioritize R&D investments and strategic alliances to secure IP rights and accelerate model development. Common strategies include cross-regional licensing agreements, co-development partnerships, and vertical integration of breeding facilities. A persistent challenge is escalating compliance costs due to evolving biosecurity protocols and strain-specific regulatory requirements. Differentiation also hinges on scalable customization options, with some firms specializing in niche applications like neurodegenerative disease models.

Charles River Laboratories: Innovation pipeline for CRISPR-based models

Envigo: Regional expansion in APAC through local manufacturing hubs

Taconic Biosciences: Vertical integration of breeding and cryopreservation services

Jackson Laboratory: OEM tie-ups for standardized model distribution

Shanghai Model Organisms Center, Inc.: Cost-competitive local supply chain

GenOway: Premium pricing for proprietary humanized mouse strains

Key Genetically Modified Rat Companies16 items

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Shanghai Model Organisms Center,Inc.

Gem Pharmatech Co.,Ltd.

Shanghai SLAC

Joinn Laboratories

Crown Biosciences

Pharmalegacy

Syngene International

Janvier Labs

GenOway

Psychogenics

Horizon Discovery Group

Vitalstar Biotechnology

Market Ecosystem

The Genetically Modified Rat ecosystem spans upstream technology development, midstream model creation, and downstream research applications. Value is generated through specialized gene-editing tools, customized rat model development, and regulated distribution to end users. The ecosystem is shaped by scientific innovation, compliance frameworks, and demand for precise preclinical research models.

Gene Editing Technology Providers — supply CRISPR-Cas9 tools and gene synthesis services for model development

Biotech Research Labs — engineer genetically modified rat strains with specific phenotypes for study

Contract Research Organizations (CROs) — conduct customized model development and preclinical testing for third-party clients

Academic & Government Research Institutions — utilize modified rats for biomedical research and disease mechanism studies

Pharmaceutical & Biotech Companies — deploy models for drug efficacy testing and toxicity screening

Regulatory Bodies — oversee ethical standards, biosafety protocols, and approval requirements for model use

Distributors/Suppliers — manage logistics, cryopreservation, and delivery of live or frozen rat models to end users

Control points reside in gene-editing technology licensing, regulatory approvals, and CRO partnerships. Dependency risks include access to proprietary gene-editing platforms and compliance with regional bioethics standards. Switching costs are moderate for end users due to model specificity, while interoperability between CROs and distributors ensures ecosystem flexibility.

Recent Industry Insights

The Genetically Modified Rat industry trends have seen accelerated innovation over the past 18 months, driven by advancements in CRISPR technology and growing demand for precise disease modeling. Key players have prioritized strategic partnerships to unlock niche research applications, such as collaborations between biotech firms and academic institutions to develop rats for neurodegenerative disorder studies. Mergers & acquisitions have also surged, with larger companies acquiring specialized GM rat model providers to expand their portfolios and streamline R&D pipelines.

Product/technology launches have centered on improving genetic editing precision, with startups introducing AI-integrated tools for mutation prediction. Regulatory changes in the EU and U.S. have introduced stricter guidelines for GM animal welfare, prompting industry-wide shifts toward ethical sourcing and transparent documentation. Meanwhile, consumer trends show a rising preference for customized rat models tailored to pharmaceutical and agricultural trials, reflecting broader demand for personalized research solutions. Funding rounds have reached record levels, with Series B investments fueling expansion into Asia-Pacific markets, where regulatory agility and cost efficiency are reshaping the competitive landscape.

Analyst Overview

The Genetically Modified Rat market outlook highlights robust growth potential driven by demand for advanced disease models in pharmaceutical R&D, biotechnology, and personalized medicine. Market attractiveness remains high due to the unique role of genetically modified rats in simulating human conditions like cancer, neurodegenerative disorders, and metabolic diseases. Competitive intensity is moderate, with key players leveraging proprietary gene-editing technologies and strain development capabilities. Strategic collaborations between biotech firms and research institutions underscore the sector’s innovation-driven nature.

Long-term outlook is optimistic, supported by advancements in CRISPR and synthetic biology, which enhance precision and reduce development timelines. The innovation landscape is dynamic, with a focus on multi-gene models and AI-integrated phenotyping to accelerate drug discovery. However, demand–supply balance faces challenges due to high production costs and specialized infrastructure requirements, limiting scalability for smaller firms. Key risk factors include regulatory scrutiny, ethical concerns, and competition from organoid and computational modeling alternatives. Decision-makers must prioritize sustainable R&D investment and regulatory alignment to capitalize on this niche market’s potential.

12 items

1. Executive Summary

2. Genetically Modified Rat Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Genetically Modified Rat Market Product Outlook & Forecast (2021-2033) Value (USD Billion) & Volume (K)

6.1. Global Genetically Modified Rat Market Product Outlook & Forecast (2021-2033) Value (USD Billion)

6.1.1. Global Genetically Modified Rat Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.2. Global Genetically Modified Rat Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.1.3. Global Genetically Modified Rat Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

6.2. Global Genetically Modified Rat Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Genetically Modified Rat Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Genetically Modified Rat Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Genetically Modified Rat Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Genetically Modified Rat Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Genetically Modified Rat Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global Genetically Modified Rat Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Genetically Modified Rat Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Genetically Modified Rat Market Competition by Key Manufacturers

9.1. Global Genetically Modified Rat Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Genetically Modified Rat: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Charles River Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Envigo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Taconic Biosciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Jackson Laboratory

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shanghai Model Organisms Center,Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Gem Pharmatech Co.,Ltd.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shanghai SLAC

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Joinn Laboratories

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Crown Biosciences

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Pharmalegacy

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Syngene International

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Janvier Labs

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. GenOway

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Psychogenics

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Horizon Discovery Group

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Vitalstar Biotechnology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Genetically Modified Rat Market

Figure 4: Global Genetically Modified Rat Market: Drivers

Figure 5: Global Genetically Modified Rat Market: Challenges

Figure 6: Global Genetically Modified Rat Market: Trends

Figure 7: Global Genetically Modified Rat Market: Opportunity

Figure 8: Global Genetically Modified Rat Market: Restraint

Figure 9: Global Genetically Modified Rat Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Genetically Modified Rat Market Value (USD Billion) By Region

Figure 19: Global Genetically Modified Rat Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Billion) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Billion) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Genetically Modified Rat Market Value (USD Billion) By Region

Figure 27: Global Genetically Modified Rat Market Share (%) By: Regions (2032)

Figure 28: Global Genetically Modified Rat Market Volume (K) By Region

Figure 29: Global Genetically Modified Rat Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Genetically Modified Rat Market Value (USD Billion) By Region

Figure 37: Global Genetically Modified Rat Market Share (%) By: Regions (2032)

Figure 38: Global Genetically Modified Rat Market Volume (K) By Region

Figure 39: Global Genetically Modified Rat Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Genetically Modified Rat Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global Genetically Modified Rat Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global Genetically Modified Rat Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Genetically Modified Rat Market Value (USD Billion) By Region

Table 14: Global Genetically Modified Rat Market Share (%) By Region

Table 15: North America Market Value (USD Billion) (2020-2024) By Country

Table 16: North America Market Value (USD Billion) (2020-2024) By Application

Table 17: North America Market Value (USD Billion) (2020-2024) By Types

Table 18: Europe Market Value (USD Billion) (2020-2024) By Country

Table 19: Europe Market Value (USD Billion) (2020-2024) By Application

Table 20: Europe Market Value (USD Billion) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 24: South America Market Value (USD Billion) (2020-2024) By Country

Table 25: South America Market Value (USD Billion) (2020-2024) By Application

Table 26: South America Market Value (USD Billion) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 30: Global Genetically Modified Rat Market Volume (K) By Region

Table 31: Global Genetically Modified Rat Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Genetically Modified Rat Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Genetically Modified Rat Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Genetically Modified Rat Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Charles River Laboratories Basic Information And Sales Area

Table 52: Charles River Laboratories. Products Portfolio

Table 53: Envigo Basic Information And Sales Area

Table 54: Envigo. Products Portfolio

Table 55: Taconic Biosciences Basic Information And Sales Area

Table 56: Taconic Biosciences. Products Portfolio

Table 57: Jackson Laboratory Basic Information And Sales Area

Table 58: Jackson Laboratory. Products Portfolio

Table 59: Shanghai Model Organisms Center,Inc. Basic Information And Sales Area

Table 60: Shanghai Model Organisms Center,Inc.. Products Portfolio

Table 61: Gem Pharmatech Co.,Ltd. Basic Information And Sales Area

Table 62: Gem Pharmatech Co.,Ltd.. Products Portfolio

Table 63: Shanghai SLAC Basic Information And Sales Area

Table 64: Shanghai SLAC. Products Portfolio

Table 65: Joinn Laboratories Basic Information And Sales Area

Table 66: Joinn Laboratories. Products Portfolio

Table 67: Crown Biosciences Basic Information And Sales Area

Table 68: Crown Biosciences. Products Portfolio

Table 69: Pharmalegacy Basic Information And Sales Area

Table 70: Pharmalegacy. Products Portfolio

Table 71: Syngene International Basic Information And Sales Area

Table 72: Syngene International. Products Portfolio

Table 73: Janvier Labs Basic Information And Sales Area

Table 74: Janvier Labs. Products Portfolio

Table 75: GenOway Basic Information And Sales Area

Table 76: GenOway. Products Portfolio

Table 77: Psychogenics Basic Information And Sales Area

Table 78: Psychogenics. Products Portfolio

Table 79: Horizon Discovery Group Basic Information And Sales Area

Table 80: Horizon Discovery Group. Products Portfolio

Table 81: Vitalstar Biotechnology Basic Information And Sales Area

Table 82: Vitalstar Biotechnology. Products Portfolio

Table 83: Global Market Value (USD Billion) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Billion) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Genetically Modified Rat Market Value (USD Billion) By Region

Table 92: Global Genetically Modified Rat Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Billion) (2025-2032) By Country

Table 94: North America Market Value (USD Billion) (2025-2032) By Application

Table 95: North America Market Value (USD Billion) (2025-2032) By Types

Table 96: Europe Market Value (USD Billion) (2025-2032) By Country

Table 97: Europe Market Value (USD Billion) (2025-2032) By Application

Table 98: Europe Market Value (USD Billion) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 102: South America Market Value (USD Billion) (2025-2032) By Country

Table 103: South America Market Value (USD Billion) (2025-2032) By Application

Table 104: South America Market Value (USD Billion) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 108: Global Genetically Modified Rat Market Volume (K) By Region

Table 109: Global Genetically Modified Rat Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Genetically Modified Rat Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.73 billion
Revenue forecast in 2033	3.02 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Shanghai Model Organisms Center,Inc.; Gem Pharmatech Co.,Ltd.; Shanghai SLAC; Joinn Laboratories; Crown Biosciences; Pharmalegacy; Syngene International; Janvier Labs; GenOway; Psychogenics; Horizon Discovery Group; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Supply chain fragility due to specialized breeding requirements and biosecurity protocols disrupts consistent supply, particularly amid global logistics bottlenecks and geopolitical trade tensions.

Market Segmentation

Loading chart…

Genetically Modified Rat Segmentation Breakdown13 items

Application

Drug Discovery

Basic Research

Toxicity Test

Parasitological Study

Hereditary Disease Study

Others

Types

Disease Model

Oncology Research Model

Immunological Research Model

Conventional Gene Modification Model

Others

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: High adoption due to cutting-edge infrastructure, strong private-sector funding, and a focus on precision medicine.

Europe: Regulatory alignment under the EU’s GMO Directive, coupled with cross-border collaborations in academic research.

Asia Pacific: Government grants (e.g., India’s Biotechnology Regulatory Authority) and rising demand for preclinical studies in oncology.

Latin America: Public-private partnerships enhancing lab capabilities and regional policy reforms to attract biotech investments.

Middle East & Africa: Growing healthcare modernization efforts and training programs to standardize genetic research protocols.

Competitive Landscape

Charles River Laboratories: Innovation pipeline for CRISPR-based models

Envigo: Regional expansion in APAC through local manufacturing hubs

Taconic Biosciences: Vertical integration of breeding and cryopreservation services

Jackson Laboratory: OEM tie-ups for standardized model distribution

Shanghai Model Organisms Center, Inc.: Cost-competitive local supply chain

GenOway: Premium pricing for proprietary humanized mouse strains

Key Genetically Modified Rat Companies16 items

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Shanghai Model Organisms Center,Inc.

Gem Pharmatech Co.,Ltd.

Shanghai SLAC

Joinn Laboratories

Crown Biosciences

Pharmalegacy

Syngene International

Janvier Labs

GenOway

Psychogenics

Horizon Discovery Group

Vitalstar Biotechnology

Market Ecosystem

Gene Editing Technology Providers — supply CRISPR-Cas9 tools and gene synthesis services for model development

Biotech Research Labs — engineer genetically modified rat strains with specific phenotypes for study

Contract Research Organizations (CROs) — conduct customized model development and preclinical testing for third-party clients

Academic & Government Research Institutions — utilize modified rats for biomedical research and disease mechanism studies

Pharmaceutical & Biotech Companies — deploy models for drug efficacy testing and toxicity screening

Regulatory Bodies — oversee ethical standards, biosafety protocols, and approval requirements for model use

Distributors/Suppliers — manage logistics, cryopreservation, and delivery of live or frozen rat models to end users

Recent Industry Insights

Analyst Overview

Table of Contents